Imatinib Completed Phase 3 Trials for Gastrointestinal Stromal Tumors (GISTs) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00785785A Study of Nilotinib Versus Imatinib in GIST Patients